Abstract
Human physiology is an ensemble of various biological processes spanning from intracellular molecular interactions to the whole body phenotypic response. Systems biology endures to decipher these multi-scale biological networks and bridge the link between genotype to phenotype. The structure and dynamic properties of these networks are responsible for controlling and deciding the phenotypic state of a cell. Several cells and various tissues coordinate together to generate an organ level response which further regulates the ultimate physiological state. The overall network embeds a hierarchical regulatory structure, which when unusually perturbed can lead to undesirable physiological state termed as disease. Here, we treat a disease diagnosis problem analogous to a fault diagnosis problem in engineering systems. Accordingly we review the application of engineering methodologies to address human diseases from systems biological perspective. The review highlights potential networks and modeling approaches used for analyzing human diseases. The application of such analysis is illustrated in the case of cancer and diabetes. We put forth a concept of cell-to-human framework comprising of five modules (data mining, networking, modeling, experimental and validation) for addressing human physiology and diseases based on a paradigm of system level analysis. The review overtly emphasizes on the importance of multi-scale biological networks and subsequent modeling and analysis for drug target identification and designing efficient therapies.
Similar content being viewed by others
References
Alon U (2003) Biological networks: the tinkerer as an engineer. Science 301(5641):1866–1867
Alon U (2007) Network motifs: theory and experimental approaches. Nat Rev Genet 8:450–461
Andasari V, Gerisch A, Lolas G, South A, Chaplain MJ (2011) Mathematical modeling of cancer cell invasion of tissue: biological insight from mathematical analysis and computational simulation. J Math Biol 63(1):141–171
Arrell DK, Terzic A (2010) Network systems biology for drug discovery. Clin Pharmacol Ther 88(1):120–125
Azmi AS, Wang Z, Philip PA, Mohammad RM, Sarkar FH (2010) Proof of concept: network and systems biology approaches aid in the discovery of potent anticancer drug combinations. Mol Cancer Ther 9(12):3137–3144
Bajikar S, Janes K (2012) Multiscale models of cell signaling. Ann Biomed Eng 40(11):2319–2327
Barabási A-L (2007) Network medicine—from obesity to the “diseasome”. N Engl J Med 357(4):404–407
Barkai N, Leibler S (1997) Robustness in simple biochemical networks. Nature 387(6636):913–917
Bauer-Mehren A, Furlong LI, Sanz F (2009). Pathway databases and tools for their exploitation: benefits, current limitations and challenges. Mol Syst Biol 5(Article number 290)
Becker S, Feist A, Mo M, Hannum G, Palsson B, Herrgard M (2007) Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox. Nat Protoc 2:727–738
Bergman RN (1997) The minimal model: yesterday, today and tomorrow. In: Bergman RN, Lovejoy JC (eds) The minimal model approach and determination of glucose tolerance. LSU Press, Baton Rouge, pp 3–50
Bergman RN (2001) The minimal model of glucose regulation: a biography. In: Novotny J, Green M, Boston R (eds) Mathematical modeling in nutrition and health. Kluwer Academic/Plenum, Dordrecht/New York
Bertoletti A, Maini MK, Ferrari C (2010) The host–pathogen interaction during HBV infection: immunological controversies. Antivir Ther 15(3):15–24
Bhalla US, Iyengar R (1999) Emergent properties of networks of biological signaling pathways. Science 283(5400):381–387
Bhat PJ, Darunte L, Kareenhalli V, Dandekar J, Kumar A (2011) Can metabolic plasticity be a cause for cancer? Warburg–Waddington legacy revisited. Clin Epigenet 2:113–122
Bogle IDL, Allen R, Sumner T (2010) The role of computer aided process engineering in physiology and clinical medicine. Comput Chem Eng 34(5):763–769
Botstein D, White RL, Skolnick M, Davis RW (1980) Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet 32(3):314–331
Brandman O, Ferrell JE Jr, Li R, Meyer T (2005) Interlinked fast and slow positive feedback loops drive reliable cell decisions. Science 310(5747):496–498
Butcher EC, Berg EL, Kunkel EJ (2004) Systems biology in drug discovery. Nat Biotechnol 22(10):1253–1259
Butler D (1999) Computing 2010: from black holes to biology. Nature 402(6761 Suppl):C67–C70
Chan P, Holford N (2001) Drug treatment effects on disease progression. Annu Rev Pharmacol Toxicol 41(1):625–659
Chandra N (2009) Computational systems approach for drug target discovery. Expert Opin Drug Discov 4(12):1221–1236
Chautard E, Thierry-Mieg N, Ricard-Blum S (2009) Interaction networks: from protein functions to drug discovery. A review. Pathol Biol (Paris) 57(4):324–333
Chen C-L, Tsai H-W, Wong S–S (2010a) Modeling the physiological glucose-insulin dynamic system on diabetics. J Theor Biol 265(3):314–322
Chen Q, Wang Z, Wei D (2010b) Progress in the applications of flux analysis of metabolic networks. Chin Sci Bull 55(22):2315–2322
Chen Y, Zhang W, Gan M, Jiang R (2012) Constructing human phenome-interactome networks for the prioritization of candidate gene. Stat Interface 5:137–148
Cheng TMK, Gulati S, Agius R, Bates PA (2012) Understanding cancer mechanisms through network dynamics. Briefings Funct Genomics 11(6):543–560
Chew YH, Shia YL, Lee CT, Majid FAA, Chua LS, Sarmidi MR, Aziz AR (2009) Modeling of glucose regulation and insulin-signaling pathways. Mol Cell Endocrinol 303:13–24
Cho CR, Labow M, Reinhardt M, van Oostrum J, Peitsch MC (2006) The application of systems biology to drug discovery. Curr Opin Chem Biol 10(4):294–302
Cho B-K, Charusanti P, Herrgård MJ, Palsson B (2007) Microbial regulatory and metabolic networks. Curr Opin Biotechnol 18(4):360–364
Cloutier M, Wang E (2011) Dynamic modeling and analysis of cancer cellular network motifs. Integr Biol 3(7):724–732
Comen E, Morris P, Norton L (2012) Translating mathematical modeling of tumor growth patterns into novel therapeutic approaches for breast cancer. J Mammary Gland Biol Neoplasia 17(3–4):241–249
Csete ME, Doyle JC (2002) Reverse engineering of biological complexity. Science 295(5560):1664–1669
Cuccato G, Gatta GD, di Bernardo D (2009) Systems and synthetic biology: tackling genetic networks and complex diseases. Heredity 102(6):527–532
Dalla Man C, Rizza RA (2007) Meal simulation model of the glucose–insulin system. IEEE Trans Biomed Eng 54:10
De Gaetano A, Hardy T, Beck B, Abu-Raddad E, Palumbo P, Bue-Valleskey J, Porksen N (2008) Mathematical models of diabetes progression. Am J Physiol Endocrinol Metab 295(6):E1462–E1479
de Graaf AA, Freidig AP, De Roos B, Jamshidi N, Heinemann M, Rullmann JAC, Hall KD, Adiels M, van Ommen B (2009) Nutritional systems biology modeling: from molecular mechanisms to physiology. PLoS Comput Biol 5(11):e1000554
Deisboeck TS, Wang Z, Macklin P, Cristini V (2011) Multiscale cancer modeling. Annu Rev Biomed Eng 13(1):127–155
del Sol A, Balling R, Hood L, Galas D (2010) Diseases as network perturbations. Curr Opin Biotechnol 21:566–571
Duda DG, Munn LL, Jain RK (2013) Can we identify predictive biomarkers for antiangiogenic therapy of cancer using mathematical modeling? J Natl Cancer Inst 105(11):762–765
Duffy BC, Zhu L, Decornez H, Kitchen DB (2012) Early phase drug discovery: cheminformatics and computational techniques in identifying lead series. Bioorg Med Chem 20(18):5324–5342
Dunker AK, Lawson JD, Brown CJ et al (2001) Intrinsically disordered protein. J Mol Graph Model 19:26–59
Edelman LB, Eddy JA, Price ND (2010) In silico models of cancer. Wiley Interdiscip Rev Syst Biol Med 2(4):438–459
Eissing T, Kuepfer L, Becker C, Block M, Coboeken K et al (2011) A computational systems biology software platform for multiscale modeling and simulation: integrating whole-body physiology, disease biology, and molecular reaction networks. Front Physiol 2(4):1–10
Erler JT, Linding R (2010) Network-based drugs and biomarkers. J Pathol 220(2):290–296
Ferrell JE (2002) Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. Curr Opin Cell Biol 14(2):140–148
Folger O, Jerby L, Frezza C, Gottlieb E, Ruppin E, Shlomi T (2011) Predicting selective drug targets in cancer through metabolic networks. Mol Syst Biol 7(501):1–10
Ge H, Walhout AJM, Vidal M (2003) Integrating ‘omic’ information: a bridge between genomics and systems biology. Trends Genet 19(10):551–560
Gehlenborg N, O’Donoghue SI, Baliga NS et al (2010) Visualization of omics data for systems biology. Nat Methods 7(3s):S56–S68
Ghosh S, Young DL, Gadkar KG, Wennerberg L, Basu K (2007) Towards optimal virtual patients: an online adaptive control approach. Engineering in Medicine and Biology Society, 2007. EMBS 2007. In: 29th Annual international conference of the IEEE
Giri L, Mutalik V, Venkatesh K (2004) A steady state analysis indicates that negative feedback regulation of PTP1B by Akt elicits bistability in insulin-stimulated GLUT4 translocation. Theor Biol Med Model 1(1):2
Goh K-I, Cusick ME, Valle D, Childs B, Vidal M, Barabasi A-L (2007) The human disease network. PNAS 104(21):8685–8690
Hageman BR, Trichler DL, Gaile DP (2012) Mathematical and statistical modeling in cancer systems biology. Front Physiol 3(227):1–8
Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA (2005) Online Mendelian inheritance in man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 33(suppl 1):D514–D517
Handorf T, Klipp E (2012) Modeling mechanistic biological networks: an advanced Boolean approach. Bioinformatics 28(4):557–563
Hartwell LH, Hopfield JJ, Leibler S, Murray AW (1999) From molecular to modular cell biology. Nature 402:C47–C52
Hase T, Tanaka H, Suzuki Y, Nakagawa S, Kitano H (2009) Structure of protein interaction networks and their implications on drug design. PLoS Comput Biol 5(10):e1000550
Heiner M, Gilbert D (2013) BioModel engineering for multiscale systems biology. Prog Biophys Mol Biol 111(2–3):119–128
Herrgård MJ, Covert MW, Palsson BØ (2004) Reconstruction of microbial transcriptional regulatory networks. Curr Opin Biotechnol 15(1):70–77
Houtman JCD, Barda-Saad M, Samelson LE (2005) Examining multiprotein signaling complexes from all angles. FEBS J 272(21):5426–5435
Hunter P, Smith N, Fernandez J, Tawhai M (2005) Integration from proteins to organs: the IUPS physiome project. Mech Ageing Dev 126(1):187–192
Hunter P, Chapman T, Coveney PV et al (2013) A vision and strategy for the virtual physiological human: 2012 update. Interface Focus 3(2):2042–8901
Imms R, Warburton C, Summers R (2011) Engineering biology: model conceptualisation and realisation. Meas Control 44(6):175–179
Janes KA, Yaffe MB (2006) Data-driven modelling of signal-transduction networks. Nat Rev Mol Cell Biol 7(11):820–828
Jordán F, Nguyen TP, Liu W (2012) Studying protein–protein interaction networks: a systems view on diseases. Briefings Funct Genomics 11(6):497–504
Jørgensen C, Linding R (2008) Directional and quantitative phosphorylation networks. Briefings Funct Genomics Proteomics 7(1):17–26
Kahraman A, Avramov A, Nashev LG et al (2005) PhenomicDB: a multi-species genotype/phenotype database for comparative phenomics. Bioinformatics 21:418–420
Kann MG (2007) Protein interactions and disease: computational approaches to uncover the etiology of diseases. Briefings Bioinform 8(5):333–346
Karp PD, Ouzounis CA, Moore-Kochlacs C, Goldovsky L et al (2005) Expansion of the BioCyc collection of pathway/genome databases to 160 genomes. Nucleic Acids Res 33(19):6083–6089
Kholodenko BN (2006) Cell-signalling dynamics in time and space. Nat Rev Mol Cell Biol 7(3):165–176
Kholodenko BN, Kiyatkin A, Bruggeman F, Sontag E, Westerhoff HV, Hoek JB (2002) Untangling the wires: a strategy to trace functional interactions in signaling and gene networks. Proc Natl Acad Sci 99(20):12841–12846
Kholodenko B, Yaffe MB, Kolch W (2012) Computational approaches for analyzing information flow in biological networks. Sci Signal 5(220):re1
Kim J, Saidel G, Cabrera M (2007) Multi-scale computational model of fuel homeostasis during exercise: effect of hormonal control. Ann Biomed Eng 35(1):69–90
Kim TY, Kim HU, Lee SY (2010) Data integration and analysis of biological networks. Curr Opin Biotechnol 21(1):78–84
Kim HU, Sohn SB, Lee SY (2012) Metabolic network modeling and simulation for drug targeting and discovery. Biotechnol J 7(3):330–342
Kirouac DC, Ito C, Csaszar E, Roch A, Yu M, Sykes EA, Bader GD, Zandstra PW (2010) Dynamic interaction networks in a hierarchically organized tissue. Mol Syst Biol 6(417):1–17
Kitano H (2002a) Computational systems biology. Nature 420(6912):206–210
Kitano H (2002b) Systems biology: A brief overview. Science 295(5560):1662–1664
Kitano H (2007) Towards a theory of biological robustness. Mol Syst Biol 3(137):1–7
Kitano H, Oda K, Kimura T, Matsuoka Y, Csete M, Doyle J, Muramatsu M (2004) Metabolic syndrome and robustness tradeoffs. Diabetes 53(suppl 3):S6–S15
Klinke D (2008) Integrating epidemiological data into a mechanistic model of type 2 diabetes: validating the prevalence of virtual patients. Ann Biomed Eng 36(2):321–334
Klipp E, Wade RC, Kummer U (2010) Biochemical network-based drug-target prediction. Curr Opin Biotechnol 21(4):511–516
Kolodkin A, Boogerd FC, Plant N, Bruggeman FJ, Goncharuk V et al (2012) Emergence of the silicon human and network targeting drugs. Eur J Pharm Sci 46(4):190–197
Koschorreck M, Conzelmann H, Ebert S, Ederer M, Gilles E (2007) Reduced modeling of signal transduction—a modular approach. BMC Bioinformatics 8(1):336
Koshiyama H, Ogawa Y, Tanaka K, Tanaka I (2010) Integrated network systems and evolutionary developmental endocrinology. Med Hypotheses 74(1):132–138
Koster ES, Rodin AS, Raaijmakers JA, Maitland-vander Zee A-H (2009) Systems biology in pharmacogenomic research: the way to personalized prescribing? Pharmacogenomics 10(6):971–981
Koyutürk M (2010) Algorithmic and analytical methods in network biology. Wiley Interdiscip Rev Syst Biol Med 2(3):277–292
Kumar N, Hendriks BS, Janes KA, de Graaf D, Lauffenburger DA (2006) Applying computational modeling to drug discovery and development. Drug Discovery Today 11(17–18):806–811
Lage K, Karlberg EO, Storling ZM, Olason PI, Pedersen AG, Rigina O, Hinsby AM, Tumer Z, Pociot F, Tommerup N, Moreau Y, Brunak S (2007) A human phenome-interactome network of protein complexes implicated in genetic disorders. Nat Biotechnol 25(3):309–316
Langley SR, Dwyer J, Drozdov I, Yin X, Mayr M (2013) Proteomics: from single molecules to biological pathways. Cardiovasc Res 97(4):612–622
Le Novère N, Bornstein B, Broicher A, Courtot M, Donizelli M, Dharuri H, Li L, Sauro H, Schilstra M, Shapiro B, Snoep JL, Hucka M (2006) BioModels Database: a free, centralized database of curated, published, quantitative kinetic models of biochemical and cellular systems. Nucleic Acids Res 34(Database issue):D689–D691
Lesko L, Atkinson A (2001) Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. Annu Rev Pharmacol Toxicol 41(1):347–366
Liu B, Thagrajan PS (2012) Modeling and analysis of biopathways dynamics. J Bioinform Comput Biol 10(04):1231001
Liu W, Hsin CC, Tang F (2009) A molecular mathematical model of glucose mobilization and uptake. Math Biosci 221:121–129
Maayan A (2011) Introduction to network analysis in systems biology. Sci Signal 4(190):tr5, 1–11
Macé G, Bogliolo M, Guervilly J-H, Dugas du Villard JA, Rosselli F (2005) 3R coordination by Fanconi anemia proteins. Biochimie 87(7):647–658
Makroglou A, Li J, Kuang Y (2006) Mathematical models and software tools for the glucose-insulin regulatory system and diabetes: an overview. Appl Numer Math 56:559–573
Mardinoglu A, Nielsen J (2012) Systems medicine and metabolic modelling. J Intern Med 271(2):142–154
Mayer B (1999) Protein–protein interactions in signaling cascades. Mol Biotechnol 13(3):201–213
Meeting H (2007) Computer modeling of diabetes and its complications. Diabetes Care 30(6):1638–1646
Menolascina F, Siciliano V, di Bernardo D (2012) Engineering and control of biological systems: a new way to tackle complex diseases. FEBS Lett 586(15):2122–2128
Milo R, Shen-Orr S, Itzkovitz S, Kashtan N, Chklovskii D, Alon U (2002) Network motifs: simple building blocks of complex networks. Science 298:824–827
Miyatsuka H, Matsuoka T, Kaneto H (2008) Transcription factors as therapeutic targets for diabetes. Expert Opin Ther Targets 12(11):1431–1442
Mizushima T (2012) Identification of molecular mechanism for actions of existing medicines and its application for drug development. Yakugaku Zasshi 132(6):713–720
Moller DE (2001) New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414(6865):821–827
Moreno-Sánchez R, Saavedra E, Rodríguez-Enríquez S, Olín-Sandoval V (2008) Metabolic control analysis: a tool for designing strategies to manipulate metabolic pathways. J Biomed Biotechnol (Article ID 597913):30
Neduva V, Russell RB (2006) Peptides mediating interaction networks: new leads at last. Curr Opin Biotechnol 17(5):465–471
Nielsen J (2012) Translational and systems medicine. J Intern Med 271(2):108–110
Oberhardt M, Palsson B, Papin J (2009) Applications of genome-scale metabolic reconstructions. Mol Syst Biol 5(320):1–15
Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M (1999) KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 27(1):29–34
Orth J, Thiele I, Palsson B (2010) What is flux balance analysis? Nat Biotechnol 28:245–248
Papin JA, Hunter T, Palsson BO, Subramaniam S (2005) Reconstruction of cellular signalling networks and analysis of their properties. Nat Rev Mol Cell Biol 6(2):99–111
Park J, Lee D-S, Christakis N, Barabasi A-L (2009) The impact of cellular networks on disease comorbidity. Mol Syst Biol 5:262
Pattaranit R, van den Berg HA (2008) Mathematical models of energy homeostasis. J R Soc Interface 5(27):1119–1135
Perez-Iratxeta C, Bork P, Andrade MA (2002) Association of genes to genetically inherited diseases using data mining. Nat Genet 31(3):316–319
Pfau T, Christian N, Ebenhöh O (2011) Systems approaches to modelling pathways and networks. Briefings Funct Genomics 10(5):266–279
Post TM, Freijer JI, DeJongh J, Danhof M (2005) Disease system analysis: basic disease progression models in degenerative disease. Pharm Res 22(7):1038–1049
Przytycka T, Kim Y-A (2010) Network integration meets network dynamics. BMC Biol 8(1):48
Pujol A, Farre J, Aloy P (2010) Unveiling the role of network and systems biology in drug discovery. Trends Pharmacol Sci 31(3):115–123
Qi Y, Ge H (2006) Modularity and dynamics of cellular networks. PLoS Comput Biol 2(12):e174
Rao CV, Arkin AP (2001) Control motifs for intracellular regulatory networks. Annu Rev Biomed Eng 3(1):391–419
Rees SE, Carson ER, Feng DD, Andreassen S (2011) Modelling and control in biomedical systems. Comput Methods Programs Biomed 104(2):27–28
Renner S, Popov M, Schuffenhauer A, Roth H-J, Breitenstein W, Marzinzik A, Lewis I, Krastel P, Nigsch F, Jenkins J, Jacoby E (2011) Recent trends and observations in the design of high-quality screening collections. Future Med Chem 3(6):751–766
Resendis-Antonio O, Checa A, Encarnación S (2010) Modeling core metabolism in cancer cells: surveying the topology underlying the Warburg effect. PLoS ONE 5(8):e12383
Rolfsson O, Palsson B, Thiele I (2011) The human metabolic reconstruction Recon 1 directs hypotheses of novel human metabolic functions. BMC Syst Biol 5(1):155
Roy A, Parker RS (2006) Dynamic modeling of free fatty acid, glucose, and insulin: an extended “minimal model”. Diabetes Technol Ther 8:617–626
Safran M, Chalifa-Caspi V, Shmueli O et al (2003) Human gene-centric databases at the Weizmann Institute of Science: GeneCards, UDB, CroW 21 and HORDE. Nucleic Acids Res 31(1):142–146
Sam L, Liu Y, Jianrong L et al (2007) Discovery of protein interaction networks shared by diseases. Pac Symp Biocomput 12:76–87
Sangar V, Eddy JA, Simeonidis E, Price N (2012) Mechanistic modeling of aberrant energy metabolism in human disease. Front Physiol 3(404):1–10
Schenone M, Dančík V, Wagner BK, Clemons PA (2013), Target identification and mechanism of action in chemical biology and drug discovery. Nat Chem Biol 9:232–240
Schleich K, Lavrik I (2013) Mathematical modeling of apoptosis. Cell Commun Signal 11(1):44
Scriver CR, Waters PJ (1999) Monogenic traits are not simple: lessons from phenylketonuria. Trends Genet 15:267–272
Sedaghat AR, Sherman A, Quon MJ (2002) A mathematical model of metabolic insulin signaling pathways. Am J Physiol Endocrinol Metab 283(5):E1084–E1101
Sesti G (2006) Pathophysiology of insulin resistance. Best Pract Res Clin Endocrinol Metab 20(4):665–679
Shahrezaei V, Swain PS (2008) The stochastic nature of biochemical networks. Curr Opin Biotechnol 19(4):369–374
Sharan TI (2008) Protein networks in disease. Genome Res 18:644–652
Smith C (2003) Drug target validation: hitting the target. Nature 422(6929):341–347
Smith JMD, Maas JA, Garnsworthy PC, Owen MR, Coombes S, Pillay TS, Barrett DA, Symonds ME (2009) Mathematical modeling of glucose homeostasis and its relationship with energy balance and body fat. Obesity 17(4):632–639
Sriram G, Liao JC, Dipple KM (2005) A comprehensive insulin signaling model for predicting phenotypes using expression data. Abstract, AICHE Annual meeting 2005
Stelling J, Sauer U, Szallasi Z, Doyle Iii FJ, Doyle J (2004) Robustness of cellular functions. Cell 118(6):675–685
Tegnér JN, Compte A, Auffray C et al (2009) Computational disease modeling—fact or fiction? BMC Syst Biol 3(56):1–3
Terentiev A, Moldogazieva N, Shaitan K (2009) Dynamic proteomics in modeling of the living cell. Protein–protein interactions. Biochem (Moscow) 74(13):1586–1607
Tiffin N, Adie E, Turner F, Brunner HG, van Driel MA, Oti M, Lopez-Bigas N, Ouzounis C, Perez-Iratxeta C, Andrade-Navarro MA, Adeyemo A, Patti ME, Semple CAM, Hide W (1980) Computational disease gene identification: a concert of methods prioritizes type 2 diabetes and obesity candidate genes. Nucleic Acids Res 34(10):3067–3081
Topp B, Promislow K, Devries G, Miuraa RM, Finegood DT (2000) A model of b-cell mass, insulin, and glucose kinetics: pathways to diabetes. J Theor Biol 206:605–619
Tripathy D, Chavez AO (2010) Defects in insulin secretion and action in the pathogenesis of type 2 diabetes mellitus. Curr Diab Rep 10:184–191
Tyson JJ, Chen K, Novak B (2001) Network dynamics and cell physiology. Nat Rev Mol Cell Biol 2(12):908–916
van Driel MA, Cuelenaere K, Kemmeren PPCW, Leunissen JAM, Brunner HG, Vriend G (2005) GeneSeeker: extraction and integration of human disease-related information from web-based genetic databases. Nucleic Acids Res 33(suppl 2):W758–W761
Verkhedkar KD, Raman K, Chandra NR, Vishveshwara S (2007) Metabolome based reaction graphs of M. tuberculosis and M. leprae: a comparative network analysis. PLoS ONE 2(9):e881
Vicini P (2008) Kinetic models at the intersection of biology, engineering and medicine. Drug Discov Today Dis Model 5(4):271–272
Vicini P, Caumo A, Cobelli C (1999) Glucose effectiveness and insulin sensitivity from the minimal models: consequences of undermodeling assessed by Monte Carlo simulation. IEEE Trans Biomed Eng 46(2):130–137
Walpole J, Papin JA, Peirce SM (2013) Multiscale computational models of complex biological systems. Annu Rev Biomed Eng 15(1):137–154
Wang E (2010) A roadmap of cancer systems biology. Nature proceedings. http://hdl.handle.net/10101/npre.2010.4322.2
Wang E, Lenferink A, O’Connor-McCourt M (2007) Genetic studies of diseases. Cell Mol Life Sci 64(14):1752–1762
Wang J, Zhang L, Jing C, Ye G, Wu H, Miao H, Wu Y, Zhou X (2013) Multi-scale agent-based modeling on melanoma and its related angiogenesis analysis. Theor Biol Med Model 10(1):41
Wells JA, McClendon CL (2007) Reaching for high-hanging fruit in drug discovery at protein–protein interfaces. Nature 450(7172):1001–1009
Werner B, Dingli D, Traulsen A (2013) A deterministic model for the occurrence and dynamics of multiple mutations in hierarchically organized tissues. J R Soc Interface 10(85):1–10
Wilkinson DJ (2009) Stochastic modelling for quantitative description of heterogeneous biological systems. Nat Rev Genet 10(2):122–133
Winslow RL, Trayanova N, Geman D, Miller MI (2012) Computational medicine: translating models to clinical care. Sci Transl Med 4(158):158rv111
Wolf DM, Arkin AP (2003) Motifs, modules and games in bacteria. Curr Opin Microbiol 6(2):125–134
Yildirim MA, Goh K, Cusick ME, Cusick ME, Barabási A-L, Vidal M (2007) Drug-target network. Nat Biotechnol 25(10):1119–1126
Zanzoni A, Soler-López M, Aloy P (2009) A network medicine approach to human disease. FEBS Lett 583:1759–1765
Zelezniak A, Pers T, Soares S, Patti M, Patil K (2010) Metabolic network topology reveals transcriptional regulatory signatures of type 2 diabetes. PLoS Comput Biol 6:e1000729
Zheng Y, Moore H, Piryatinska A, Solis T, Sweet-Cordero EA (2013) Mathematical modeling of tumor cell proliferation kinetics and label retention in a mouse model of lung cancer. Cancer Res 73(12):3525–3533
Zhu X, Gerstein M, Snyder M (2007) Getting connected: analysis and principles of biological networks. Genes Dev 21:1010–1024
Zhu M, Gao L, Li X, Liu Z, Xu C, Yan Y, Walker E et al (2009) The analysis of the drug-targets based on the topological properties in the human protein–protein interaction network. J Drug Target 17(7):524–532
Zinovyev A, Fourquet S, Tournier L, Calzone L, Barillot E (2012) Cell death and life in cancer: mathematical modeling of cell fate decisions. Adv Expt Med Biol 736:261–274
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Somvanshi, P.R., Venkatesh, K.V. A conceptual review on systems biology in health and diseases: from biological networks to modern therapeutics. Syst Synth Biol 8, 99–116 (2014). https://doi.org/10.1007/s11693-013-9125-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11693-013-9125-3